Mohamed A Kamal Selected Research

Interleukin-4 (Interleukin 4)

1/2023	Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma.
12/2022	Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.
1/2022	Pharmacokinetics and Concentration-Response of Dupilumab in Patients With Seasonal Allergic Rhinitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohamed A Kamal Research Topics

Disease

10	Atopic Dermatitis (Atopic Eczema) 11/2023 - 01/2020
6	Human Influenza (Influenza) 11/2023 - 02/2013
6	Body Weight (Weight, Body) 11/2023 - 08/2013
5	Infections 11/2023 - 07/2015
5	Eczema 11/2023 - 01/2020
4	Asthma (Bronchial Asthma) 01/2023 - 01/2021
4	Conjunctivitis 01/2022 - 01/2020
3	Inflammation (Inflammations) 01/2023 - 01/2022
3	Hypersensitivity (Allergy) 01/2022 - 11/2021
2	Allergic Rhinitis 12/2022 - 01/2022
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2015 - 04/2015
1	Eosinophilic Esophagitis 12/2022
1	Disease Progression 12/2022
1	Ebola Hemorrhagic Fever 10/2022
1	Hemorrhage 10/2022
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Blepharitis 01/2021
1	Keratitis 01/2021
1	Injection Site Reaction 01/2020
1	Erythema 07/2015
1	Exanthema (Rash) 07/2015
1	Anuria 04/2015
1	Non-alcoholic Fatty Liver Disease 01/2013
1	Insulin Resistance 01/2013
1	Sleepiness 08/2010
1	Dizziness (Lightheadedness) 08/2010
1	Communicable Diseases (Infectious Diseases) 01/2008
1	Porphyrias (Porphyria) 01/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2004

Drug/Important Bio-Agent (IBA)

13	dupilumabIBA 11/2023 - 01/2020
9	Monoclonal AntibodiesIBA 12/2022 - 11/2021
8	Oseltamivir (Tamiflu)FDA Link 11/2023 - 02/2013
4	Immunoglobulin A (IgA)IBA 11/2023 - 01/2020
4	AllergensIBA 12/2022 - 11/2021
4	oseltamivir carboxylateIBA 01/2017 - 06/2015
3	Interleukin-4 (Interleukin 4)IBA 01/2023 - 01/2022
3	Immunoglobulin G (IgG)IBA 01/2022 - 11/2021
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 09/2004
2	Interleukin-13IBA 12/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2017
2	AntibodiesIBA 01/2022 - 01/2020
2	AlbuminsIBA 11/2021 - 01/2020
1	Chemokine CCL17IBA 11/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	VaccinesIBA 12/2022
1	CreatinineIBA 10/2022
1	NitrogenIBA 10/2022
1	atoltivimab, maftivimab, and odesivimab-ebgn drug combinationIBA 10/2022
1	Urea (Carbamide)FDA LinkGeneric 10/2022
1	Alanine (L-Alanine)FDA Link 10/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2022
1	itepekimabIBA 01/2022
1	Interleukin-33IBA 01/2022
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Combined Antibody TherapeuticsIBA 01/2022
1	Immunoglobulin IsotypesIBA 01/2022
1	InterleukinsIBA 01/2022
1	ML 23IBA 07/2015
1	Phosphates (Orthophosphate)IBA 06/2015
1	Neuraminidase (Sialidase)IBA 02/2013
1	Nonesterified Fatty Acids (NEFA)IBA 01/2013
1	EnzymesIBA 01/2013
1	Triglycerides (Triacylglycerol)IBA 01/2013
1	Lorazepam (Ativan)FDA LinkGeneric 08/2010
1	AcidsIBA 01/2008
1	Cefadroxil (Duricef)FDA LinkGeneric 01/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2008
1	PeptidomimeticsIBA 01/2008
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2004
1	Prednisolone (Predate)FDA LinkGeneric 09/2004

Therapy/Procedure

3	Therapeutics 01/2022 - 09/2004
1	Immunotherapy 01/2022
1	Renal Dialysis (Hemodialysis) 11/2015
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 04/2015
1	Peritoneal Dialysis 04/2015